Literature DB >> 12957214

Putative anxiety-linked effects of the nitric oxide synthase inhibitor L-NAME in three murine exploratory behavior models.

Donald A Czech1, Erika B Jacobson, Kolitta T LeSueur-Reed, Melanie R Kazel.   

Abstract

The aim of the current study was to extend investigation into possible linkage between nitric oxide (NO) and anxiety-linked behavior using a battery of tests. Effects of the NO synthase (NOS) inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) were investigated in three murine models of anxiety-the light-dark, hole-board and elevated plus-maze-in between-groups designs. Treatment groups included L-NAME (0 [vehicle, or Veh], 10, 25, and 50 mg/kg) and 50 mg/kg of the inactive isomer N(G)-nitro-D-arginine methyl ester (D-NAME) injected subcutaneously. Mice exhibited a robust anxiogenic-like response profile reflected by dose-related decreases in both light-dark (transitions and time in lighted area) and hole-board (head dips and time spent head dipping) test measures, reaching statistical significance at 25 and 50 mg/kg L-NAME when compared to Veh controls (P<.05 or.01; Dunnett's t test), while distance traveled and rearing showed no significant differential pattern in either model. In both models, there was a strong dissociation between nonspecific locomotion and putative exploratory behaviors. D-NAME was not significantly different from Veh condition in either model, indicating a stereospecific action and supporting NO involvement. A dose-related decrease was also observed for several traditional and ethological measures in the plus-maze; however, the effect was limited and relatively weak or absent; with the exception of open-arm and percent open-arm entries, putative anxiety-sensitive measures reached statistical significance only at the highest dose. Reductions in motor activity compromised ability to dissociate an anxiety linkage from a nonspecific motor effect in most measures. It is concluded that the hole-board and light-dark tests provide indication of anxiogenic-like action of NOS inhibition, suggesting that NO has an anxiolytic action. Data from the plus-maze are unclear, owing to a confounding motor influence in most measures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957214     DOI: 10.1016/s0091-3057(03)00149-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of mice.

Authors:  S K Segall; A G Nackley; L Diatchenko; W R Lariviere; X Lu; J S Marron; L Grabowski-Boase; J R Walker; G Slade; J Gauthier; J S Bailey; B M Steffy; T M Maynard; L M Tarantino; T Wiltshire
Journal:  Genes Brain Behav       Date:  2010-11       Impact factor: 3.449

2.  Inhibition of neuronal nitric oxide reduces anxiety-like responses to pair housing.

Authors:  Joanna L Workman; Brian C Trainor; M Sima Finy; Randy J Nelson
Journal:  Behav Brain Res       Date:  2007-09-04       Impact factor: 3.332

Review 3.  Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide.

Authors:  Natalia Sestakova; Angelika Puzserova; Michal Kluknavsky; Iveta Bernatova
Journal:  Interdiscip Toxicol       Date:  2013-09

Review 4.  The role of brain gaseous neurotransmitters in anxiety.

Authors:  Artur Pałasz; Itiana Castro Menezes; John J Worthington
Journal:  Pharmacol Rep       Date:  2021-03-13       Impact factor: 3.024

Review 5.  Nitric Oxide Synthase Inhibitors as Antidepressants.

Authors:  Gregers Wegener; Vallo Volke
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.